血清HER2/neu在HER2过表达型乳腺癌新辅助化疗中的变化及意义 |
| |
引用本文: | 姚宇锋,马蓉,龚建平,秦建伟,唐金海.血清HER2/neu在HER2过表达型乳腺癌新辅助化疗中的变化及意义[J].内分泌外科杂志,2013(5):368-370,383. |
| |
作者姓名: | 姚宇锋 马蓉 龚建平 秦建伟 唐金海 |
| |
作者单位: | [1]江苏省肿瘤医院普外科,210009 [2]江苏省肿瘤医院科研科,210009 |
| |
基金项目: | 江苏省第四期"333工程"科研项目资助(BRA201114) |
| |
摘 要: | 目的 探讨在人表皮生长因子受体2(human epidermal growth factor receptor2,HER2)过表达型乳腺癌新辅助化疗中血清HER2/neu浓度的变化及其与疗效的相关性.方法 采用酶联免疫法检测78例HER2过表达型局部进展期乳腺癌患者新辅助化疗前后血清HER2/neu的浓度,分析其变化与新辅助化疗疗效的相关性.结果 HER2过表达型乳腺癌患者新辅助化疗前后血清HER2/neu的浓度分别为(18.6±10.0) ng/ml,(11.6±6.1)ng/ml,前后比较差异有统计学意义(P <0.001).新辅助化疗前后血清HER2/neu浓度变化与化疗疗效相关(P =0.029).新辅助化疗前后血清HER2/neu浓度变化与病理完全缓解相关(P<0.05).结论 在HER2过表达型乳腺癌患者中,新辅助化疗前后血清HER2/neu浓度变化可作为预测化疗疗效的指标.
|
关 键 词: | 乳腺肿瘤 血清HER2 neu 新辅助化疗 |
The clinical significance of the change of serum HER2/neu concentration during neoadjuvant chemotherapy of the HER2-overexpressed breast cancer |
| |
Authors: | YAO Yu-feng MA Rong GONG Jian-ping QIN Jian-wei TANG Jin-hai |
| |
Institution: | 1.Department of General Surgery, Jiangsu Cancer Hospital, Nanjing 210009, China;) |
| |
Abstract: | Objective To explore the change of serum HER2/neu concentration during neoadjuvant chemotherapy for HER2-overexpressed breast cancer and its correlation with the response to the neoadjuvant chemotherapy.Methods The concentration of the serum HER2/neu in 78 cases of HER2-overexpressed advanced breast cancer treated with neoadjuvant chemotherapy were detected with enzyme-linked immunosordent assay(ELISA).The relationship between the serum HER2/neu concentration and the response of neoadjuvant chemotherapy was analyzed.Results The serum HER2/neu concentration of befor and after neoadjuvant chemotherapy was 18.6 ± 10.0ng/ml,11.6 ± 6.lng/ml respectively.The serum HER2/neu concentration decreased significantly(P < 0.001).The response of neoadjuvant chemotherapy was correlated with the change of the serum HER2/neu concentration.The pathologic complete response was correlated with the serum HER2/neu concentration of prechemotherapy and the change of the serum HER2/neu concentration.Conclusion The change of serum HER2/neu concentration may serve as a marker predicting the response of neoadjuvant chemotherapy in HER2-overexpressed breast cancer. |
| |
Keywords: | Breast neoplasm Serum HER2/neu Neoadjuvant chemotherapy |
本文献已被 维普 等数据库收录! |